# Allogeneic UCB Therapy With EPO in Children With CP

> **NCT01991145** · NA · COMPLETED · sponsor: **MinYoung Kim, MD, PhD** · enrollment: 92 (actual)

## Conditions studied

- Cerebral Palsy

## Interventions

- **PROCEDURE:** Umbilical Cord Blood therapy
- **BIOLOGICAL:** Erythropoietin alfa
- **OTHER:** Rehabilitation
- **PROCEDURE:** Placebo UCB
- **BIOLOGICAL:** Placebo EPO

## Key facts

- **NCT ID:** NCT01991145
- **Lead sponsor:** MinYoung Kim, MD, PhD
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-11-26
- **Primary completion:** 2017-06-24
- **Final completion:** 2017-06-24
- **Target enrollment:** 92 (ACTUAL)
- **Last updated:** 2020-01-18

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01991145

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01991145, "Allogeneic UCB Therapy With EPO in Children With CP". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01991145. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*